Can a daily cosmetic keep pores clear without irritation?
NCT ID NCT07768800
First seen Aug 17, 2026 · Last updated Sep 17, 2026 · Updated 3 times
Summary
This trial evaluates whether a cosmetic product called Blancy Pro is safe and gentle for daily use on oily, acne-prone skin. About 33 women aged 18 to 45 will apply the product for 28 days under normal conditions. Researchers will check for skin irritation, discomfort, and whether the product clogs pores or causes breakouts. The goal is to confirm the product's dermatological safety and its non-comedogenic and non-acnegenic potential.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Blancy Pro, a cosmetic product for daily use on oily and acne-prone skin
- What this could lead to
- If successful, this could support Blancy Pro as a well-tolerated daily cosmetic option that does not clog pores or worsen acne.
- What could go wrong
- This is a small, early-stage study in a specific group (women with oily skin), so results may not apply to everyone. The product could still cause irritation or clog pores in some individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 33 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female participants aged 18 to 45 years. * Participants with oily and acne-prone skin. * Intact skin in the area intended for application and assessment of the investigational product. * Willingness to comply with all study procedures and attend scheduled visits and assessments. * Ability to understand the study requirements, provide written informed consent, and sign the Informed Consent Form (ICF). Exclusion Criteria: * Pregnant or breastfeeding women, or women at risk of becoming pregnant during the study. * Use of anti-inflammatory, immunosuppressive, or antihistamine medications within 3 weeks prior to screening. * Skin conditions or marks in the study area that may interfere with the evaluation of skin reactions, including vascular malformations, scars, excessive hair growth, multiple nevi, or sunburn. * History of atopic conditions or allergy to cosmetic products. * Active skin diseases and/or lesions in the assessment area or elsewhere on the body. * Immunosuppression due to medication use or active disease. * Uncontrolled endocrine disorders. * Relevant medical history or current evidence of alcohol or substance abuse. * Known history or suspected intolerance to products of the same category as the investigational product. * Intense sun exposure within 15 days prior to assessment. * Aesthetic or dermatological treatments within 4 weeks prior to assessment. * Any other condition that, in the investigator's opinion, may interfere with study participation, study evaluations, or justify exclusion from the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Oily skin are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Grupo Medcin
RECRUITINGOsasco, São Paulo, 06023-070, Brazil